Jonas Grina

1.3k total citations
15 papers, 481 citations indexed

About

Jonas Grina is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Jonas Grina has authored 15 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Jonas Grina's work include Melanoma and MAPK Pathways (10 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Cancer Mechanisms and Therapy (4 papers). Jonas Grina is often cited by papers focused on Melanoma and MAPK Pathways (10 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Cancer Mechanisms and Therapy (4 papers). Jonas Grina collaborates with scholars based in United States, New Zealand and China. Jonas Grina's co-authors include Ellen R. Laird, Frank R. Stermitz, Li Ren, Susan L. Gloor, Joshua D. Hansen, Stephen T. Schlachter, Brad Newhouse, Steve Wenglowsky, Joachim Rudolph and Matthew Martinson and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Jonas Grina

15 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonas Grina United States	12	280	203	102	75	54	15	481
Ryan Greenwood United Kingdom	10	312 1.1×	209 1.0×	79 0.8×	72 1.0×	73 1.4×	18	517
Sotiris S. Nikolaropoulos Greece	16	336 1.2×	328 1.6×	67 0.7×	57 0.8×	105 1.9×	49	637
Michael R. Michaelides United States	16	261 0.9×	338 1.7×	70 0.7×	44 0.6×	155 2.9×	24	633
Ligang Qian United States	14	311 1.1×	341 1.7×	51 0.5×	22 0.3×	91 1.7×	19	649
Kurt G. Pike United Kingdom	16	633 2.3×	210 1.0×	66 0.6×	39 0.5×	131 2.4×	37	863
David G. Hulcoop United Kingdom	12	284 1.0×	442 2.2×	41 0.4×	73 1.0×	26 0.5×	20	857
Timothy P. Heffron United States	14	322 1.1×	297 1.5×	46 0.5×	71 0.9×	200 3.7×	21	808
Clive McCarthy United Kingdom	16	255 0.9×	271 1.3×	28 0.3×	64 0.9×	68 1.3×	29	673
Ingo V. Hartung Germany	14	315 1.1×	477 2.3×	56 0.5×	56 0.7×	70 1.3×	36	906
Frederick W. Goldberg United Kingdom	15	320 1.1×	418 2.1×	53 0.5×	63 0.8×	95 1.8×	35	807

Countries citing papers authored by Jonas Grina

Since Specialization

Citations

This map shows the geographic impact of Jonas Grina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Grina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Grina more than expected).

Fields of papers citing papers by Jonas Grina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Grina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Grina. The network helps show where Jonas Grina may publish in the future.

Co-authorship network of co-authors of Jonas Grina

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Grina. A scholar is included among the top collaborators of Jonas Grina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Grina. Jonas Grina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Xu, Rui, Keshi Wang, James P. Rizzi, et al.. (2019). 3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma. Journal of Medicinal Chemistry. 62(15). 6876–6893. 156 indexed citations

Ren, Li, Jonas Grina, David Moreno‐Mateos, et al.. (2015). Discovery of Highly Potent, Selective, and Efficacious Small Molecule Inhibitors of ERK1/2. Journal of Medicinal Chemistry. 58(4). 1976–1991. 33 indexed citations

Wenglowsky, Steve, Li Ren, Jonas Grina, et al.. (2014). Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 24(8). 1923–1927. 16 indexed citations

Wenglowsky, Steve, Jonas Grina, Ellen R. Laird, et al.. (2013). Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 23(21). 5896–5899. 24 indexed citations

Cui, Yong, Po‐Chang Chiang, Edna F. Choo, et al.. (2013). Systemic in vitro and in vivo evaluation for determining the feasibility of making an amorphous solid dispersion of a B-Raf (rapidly accelerated fibrosarcoma) inhibitor. International Journal of Pharmaceutics. 454(1). 241–248. 8 indexed citations

Ren, Li, Kateri A. Ahrendt, Jonas Grina, et al.. (2012). The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase. Bioorganic & Medicinal Chemistry Letters. 22(10). 3387–3391. 14 indexed citations

Ren, Li, Ellen R. Laird, Susan L. Gloor, et al.. (2011). Potent and selective pyrazolo[1,5-a]pyrimidine based inhibitors of B-RafV600E kinase with favorable physicochemical and pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 22(2). 1165–1168. 23 indexed citations

Choo, Edna F., Bruno Alicke, Jason Boggs, et al.. (2011). Preclinical assessment of novel BRAF inhibitors: integrating pharmacokinetic-pharmacodynamic modelling in the drug discovery process. Xenobiotica. 41(12). 1076–1087. 5 indexed citations

Wenglowsky, Steve, Kateri A. Ahrendt, Bainian Feng, et al.. (2011). Pyrazolopyridine inhibitors of B-RafV600E. Part 2: Structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 21(18). 5533–5537. 50 indexed citations

10.

Hansen, Joshua D., Jonas Grina, M. Bruce Welch, et al.. (2010). Non-oxime pyrazole based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 21(11). 3488–3492. 38 indexed citations

11.

Ren, Li, Ellen R. Laird, Steve Wenglowsky, et al.. (2010). The Discovery of furo[2,3-c]pyridine-based indanone oximes as potent and selective B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(4). 1248–1252. 22 indexed citations

12.

Hansen, Joshua D., Jonas Grina, Brad Newhouse, et al.. (2008). Potent and selective pyrazole-based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 18(16). 4692–4695. 57 indexed citations

13.

Grina, Jonas, et al.. (1986). Alkaloids from Delphinium geyeri. Three new C20-diterpenoid alkaloids. The Journal of Organic Chemistry. 51(3). 390–394. 16 indexed citations

14.

Grina, Jonas, et al.. (1982). Constituents of Zanthoxylum. 7. Old and new alkaloids from Zanthoxylum arborescens. The Journal of Organic Chemistry. 47(13). 2648–2651. 17 indexed citations

15.

Grina, Jonas & Frank R. Stermitz. (1981). (2S,5S)-2,5-dibenzyl-1,4-dimethylpiperazine, a novel alkaloid from zanthoxylum arborescens. Tetrahedron Letters. 22(52). 5257–5258. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact